Related Experiment Video
Updated: Sep 5, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Association between sarcoidosis and cardiovascular Outcomes: A systematic review and Meta-analysis
Vikash Jaiswal1, Song Peng Ang2, Zouina Sarfraz3
1AMA School Of Medicine, Makati, Philippines.
Insights
Patients with sarcoidosis face significantly higher risks of all-cause mortality, ventricular tachycardia, heart failure, and atrial arrhythmias. Early awareness and monitoring for cardiovascular events in sarcoidosis patients are crucial.
Area of Science:
- Cardiology
- Pulmonology
- Public Health
Background:
- Sarcoidosis is a chronic inflammatory disease with significant morbidity and mortality.
- Cardiovascular complications in sarcoidosis are not well-documented.
- This study investigates the association between sarcoidosis and adverse cardiovascular outcomes.
Purpose of the Study:
- To compare the incidence of adverse cardiovascular outcomes in patients with sarcoidosis versus those without.
- To quantify the risks of mortality, ventricular tachycardia, heart failure, and atrial arrhythmias in sarcoidosis patients.
Main Methods:
- A systematic review and meta-analysis of studies published up to March 2022.
- Databases searched include PubMed, Embase, and Scopus.
- Outcomes assessed: all-cause mortality (ACM), ventricular tachycardia (VT), heart failure (HF), and atrial arrhythmias (AA).
Main Results:
- Analysis included 6 studies with over 22 million participants.
- Sarcoidosis patients had significantly increased all-cause mortality (RR, 2.08).
- Higher incidence of VT (RR, 15.3), HF (RR, 4.96), and AA (RR, 2.55) observed in sarcoidosis patients.
Conclusions:
- Patients with sarcoidosis exhibit significantly higher rates of VT, HF, and AA.
- Cardiovascular events are a significant concern for individuals with sarcoidosis.
- Clinicians should maintain a high index of suspicion for these adverse cardiovascular events in sarcoidosis patients.
Background:
Sarcoidosis is a chronic inflammatory disorder of unknown etiology associated with high morbidity and mortality. Its association with cardiovascular outcomes is under-documented.
Aim:
The aim of this study was to assess the adverse cardiovascular outcomes in patients with sarcoidosis compared with that of non-sarcoidosis.
Methodology:
Online databases including PubMed, Embase and Scopus were queried from inception until March 2022. The outcomes assessed included all-cause mortality (ACM) and incidence of ventricular tachycardia (VT), heart failure (HF) and atrial arrhythmias (AA).
Result:
A total of 6 studies with 22,539,096 participants (42,763 Sarcoidosis, 22,496,354 Non-Sarcoidosis) were included in this analysis. The pooled prevalence of sarcoidosis was 13.1% (95% CI 1% to 70%). The overall mean age was 47 years. The most common comorbidities were hypertension (12.7% vs 12.5%), and diabetes mellitus (5.5% vs 4%) respectively. The pooled analysis of primary endpoints showed that all-cause mortality (RR, 2.08; 95% CI: 1.17 to 3.08; p = 0.01) was significantly increased in sarcoidosis patients. The pooled analysis of secondary endpoints showed that the incidence of VT (RR, 15.3; 95% CI: 5.39 to 43.42); p < 0.001), HF (RR, 4.96; 95% CI: 2.02 to 12.14; p < 0.001) and AA (RR, 2.55; 95% CI: 1.47 to 4.44); p = 0.01) were significantly higher with sarcoidosis respectively compared to non-sarcoidosis.
Conclusion:
Incidence of VT, HF and AA was significantly higher in patients with CS. Clinicians should be aware of these adverse cardiovascular events associated with sarcoidosis.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy